Finanzwire Finanzwire
Basculer en Français
10097 Companies
206690 Keywords
136846 Articles
109549 Press releases
Headlines Articles Press releases US Nuclear Corp Remove
  1. Home
  2. Companies
  3. US Nuclear Corp
Finanzwire
Basculer en Français
Headlines Articles Press releases

News

  • PRESS RELEASE

    published on 01/30/2024 at 14:35, 2 years 1 month ago

    US Nuclear's Medical Isotope Production to Revolutionize Healthcare

    US Nuclear Corp announces plan to bring medical isotopes to the market, reshaping healthcare with revolutionary isotope production through clean fusion power. The shortage of medical isotopes, critical for precise diagnostics, will be addressed, potentially doubling the $10 billion market and providing access to advanced care worldwide
    Healthcare US Nuclear Corp Medical Isotopes Diagnostic Imaging Fusion Power
    Logo of US Nuclear Corp
  • PRESS RELEASE

    published on 01/22/2024 at 14:38, 2 years 2 months ago

    US Nuclear Strategic Investment in Fusion Energy Breakthrough Targets $7.5 Billion Medical Radioisotope Market for First Use

    US Nuclear Corp makes a strategic investment in fusion energy breakthrough targeting the $7.5 billion medical radioisotope market. The breakthrough technology aims to produce abundant, low-cost, clean energy and meet the growing demand for medical radioisotopes with safer and more cost-effective methods. The company's recent breakthrough in neutron production positions it as a potential game-changer in the industry.
    US Nuclear Corp Fusion Energy Medical Radioisotope Market Neutron Production Clean Energy
    Logo of US Nuclear Corp
Accesswire
  • Published on 03/26/2026 at 11:07, 45 minutes ago

    U.S. Mined and Refined Metals as well as Rare Earth Elements to Be Tokenized in Historic American Strategic Minerals and Datavault AI Deal

  • Published on 03/26/2026 at 11:00, 52 minutes ago

    Pivotree Announces Fourth Quarter 2025 Results

  • Published on 03/26/2026 at 11:00, 52 minutes ago

    Stagwell Expands the Harris Poll's Harrisquest Across Europe

  • Published on 03/26/2026 at 08:05, 3 hours 47 minutes ago

    Vanta Announces U.S. Ticker Symbol Change to VNTXF

  • Published on 03/26/2026 at 04:55, 6 hours 57 minutes ago

    Vanta Announces Capital Markets Initiatives to Strengthen Financial Position and Support Growth Initiatives

View all ACCESSWIRE
EQS Group
  • Published on 03/26/2026 at 11:03, 49 minutes ago

    EQS-Adhoc: VIDINEXT AG: Marketing agreement with Telekom Deutschland GmbH

  • Published on 03/26/2026 at 11:00, 52 minutes ago

    Genel Energy PLC: Posting of Annual Report and Notice of AGM

  • Published on 03/26/2026 at 11:00, 52 minutes ago

    Genel Energy PLC: Report on payments to governments for the year 2025

  • Published on 03/26/2026 at 11:00, 52 minutes ago

    ABB Ltd: ABB share buybacks - March 19, 2026 - March 25, 2026

  • Published on 03/26/2026 at 11:00, 52 minutes ago

    Independent study reveals 44% ROI with EQS Compliance Cockpit and payback in under six months

View all EQS
Les Echos
  • Published on 03/26/2026 at 08:57, 2 hours 54 minutes ago

    Edenred statement

  • Published on 03/26/2026 at 07:30, 4 hours 22 minutes ago

    BIOPHYTIS-LYNXKITE ALLIANCE INVITED TO NVIDIA CONFERENCE: UNLEASHING AI TO REVOLUTIONIZE LONGEVITY

  • Published on 03/25/2026 at 18:53, 16 hours 59 minutes ago

    LNA SANTE : 2025 Annual Results

  • Published on 03/25/2026 at 18:31, 17 hours 21 minutes ago

    Strong investment performance and active roll-out of our strategy

  • Published on 03/25/2026 at 17:45, 18 hours 7 minutes ago

    Combined General Meeting on May 05, 2026: publication of the notice of Meeting

View all LES ECHOS COMFI WIRE

With finanzwire.com, you can follow all the latest financial news in real time from the best sources for companies listed on the Paris, Brussels, Amsterdam, Lisbon, Frankfurt and New York stock exchanges. You'll have access to summary articles written by us and press releases published by the companies themselves.

Finanzwire

87, rue Ordener - 75018 Paris

Contact us

+33 1 42 23 83 61

© 2026 Finanzwire

Contact Authors Cookies policy Terms and conditions Privacy policy